A.P. Pharma, Inc. Share Price OTC Bulletin Board
Equities
APPA
US00202J2033
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
24/06 | Heron Therapeutics, Inc.(NasdaqCM:HRTX) added to S&P Biotechnology Select Industry Index | CI |
12/06 | Connect Biopharma Names New Chief Executive, Chair | MT |
Sales 2024 * | 148M 12.33B | Sales 2025 * | 178M 14.84B | Capitalization | 502M 41.84B |
---|---|---|---|---|---|
Net income 2024 * | -14M -1.17B | Net income 2025 * | 1M 83.4M | EV / Sales 2024 * | 3.39 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.82 x |
P/E ratio 2024 * |
-37
x | P/E ratio 2025 * |
499
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.3% |
Latest transcript on A.P. Pharma, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/23/21 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 16/23/16 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/23/21 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 20/21/20 |
Craig Johnson
BRD | Director/Board Member | 62 | 13/14/13 |
1st Jan change | Capi. | |
---|---|---|
+23.13% | 46.93B | |
+37.09% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+32.23% | 12.53B | |
-6.56% | 11.36B | |
-12.56% | 10.65B |
- Stock Market
- Equities
- HRTX Stock
- APPA Stock